Natco seeks CDSCO approval for phase-III trial of Molnupiravir for COVID-19 treatment
Natco is hoping that CDSCO would give emergency approval of this drug based on compassionate use for patients.
Natco is hoping that CDSCO would give emergency approval of this drug based on compassionate use for patients.
